Hevert-Foundation and Witten/Herdecke University hold symposium on basic research in potentized medicine

A symposium on basic research in potentized medicine in early June fostered networking among academics and institutions and provided impetus for future research development. The event in Nussbaum was organized by Dr. Stephan Baumgartner, private lecturer at Witten/Herdecke University, and Sandra Würtenberger, head of basic research at Hevert-Arzneimittel, who offered a program of seven presentations on current research projects.

A presentation on research into low homeopathic potencies using the droplet evaporation method given by Dr. Mari Olga Kokornaczyk to attendees from research facilities, associations, and the industry.

The mechanism of action of potentized medicine, as used in homeopathy and anthroposophic medicine, is always a contentious issue of discussion in the media and in conventional academia. It is not widely known that research has seen significant progress in this area in recent years and that there is a large number of promising research approaches.

The roughly 60 symposium attendees learned that there are now over 2,400 published experiments in the area of basic research during the first presentation by Dr. Beate Stock-Schröer (Carstens-Stiftung). Other presentations revealed the results from experimental studies using various models such as the droplet evaporation method, transcriptome analysis, and research on human cancer cell lines. Dr. Peter Christian Endler has been conducting research on the effect potentized medicine has on biological testing systems for over 20 years. He gave a presentation with his colleague, Corinne Kraus, on the impact of potentized medicine on wheat germination.

The organizers of the event topped the symposium off with a presentation summarizing the state of experimental physical research. Based on a few physical testing methods such as NMR relation times, high-quality experimental studies have already shown differences between potentized substances and control samples even at extremely high dilutions. According to Würtenberger and Baumgartner, the aim of future physical research must now be to focus on promising approaches and to repeat studies in order to answer the question of the method of action.

Event organizers and representatives of the Hevert-Foundation, Witten/Herdecke University, and Hevert-Arzneimittel: (left to right) Anika Weisert (Head of Scientific & Regulatory Affairs at Hevert-Arzneimittel), Sarah Hevert (Chairman of the Board of Hevert-Foundation), Sandra Würtenberger (Head of Basic Research at Hevert-Arzneimittel), Dr. Stephan Baumgartner (Witten/Herdecke University), Mathias Hevert and Marcus Hevert (Members of the Board of Hevert-Foundation, Managing Directors of Hevert-Arzneimittel)

Although complementary medicine treatments may be very popular, still almost no public funds are provided for their research and further development, making this scientific field primarily reliant on support from foundations. "Particularly homeopathy – which is under constant attack from critics – needs to have research findings to stand up to these attacks. The Hevert-Foundation, which supports charitable initiatives separate from business interests, has thus supported homeopathic research since it was founded," explained Mathias Hevert, Member of the Board of the Hevert-Foundation and Managing Director of Hevert-Arzneimittel. The company conducts its own basic research and supports outside research facilities. The attendees viewed the symposium as another key step in improving networking among academics and institutions in this field and in advancing research.

This website uses cookies. By using this website, you consent to the use of cookies in accordance with our policy. OK